This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to -aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.

 
Web www.patentalert.com

< Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses

< Fibrin binding domain polypeptides and uses and methods of producing same

> Therapeutic prostatic thermotherapy

> Epothilone derivatives
~ 00230